Developmental trajectories of neuroanatomical alterations associated with the 16p11.2 Copy Number Variations.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
12 2019
Historique:
received: 11 01 2019
revised: 23 08 2019
accepted: 02 09 2019
pubmed: 9 9 2019
medline: 30 9 2020
entrez: 9 9 2019
Statut: ppublish

Résumé

Most of human genome is present in two copies (maternal and paternal). However, segments of the genome can be deleted or duplicated, and many of these genomic variations (known as Copy Number Variants) are associated with psychiatric disorders. 16p11.2 copy number variants (breakpoint 4-5) confer high risk for neurodevelopmental disorders and are associated with structural brain alterations of large effect-size. Methods used in previous studies were unable to investigate the onset of these alterations and whether they evolve with age. In this study, we aim at characterizing age-related effects of 16p11.2 copy number variants by analyzing a group with a broad age range including younger individuals. A large normative developmental dataset was used to accurately adjust for effects of age. We normalized volumes of segmented brain regions as well as volumes of each voxel defined by tensor-based morphometry. Results show that the total intracranial volumes, the global gray and white matter volumes are respectively higher and lower in deletion and duplication carriers compared to control subjects at 4.5 years of age. These differences remain stable through childhood, adolescence and adulthood until 23 years of age (range: 0.5 to 1.0 Z-score). Voxel-based results are consistent with previous findings in 16p11.2 copy number variant carriers, including increased volume in the calcarine cortex and insula in deletions, compared to controls, with an inverse effect in duplication carriers (1.0 Z-score). All large effect-size voxel-based differences are present at 4.5 years and seem to remain stable until the age of 23. Our results highlight the stability of a neuroimaging endophenotype over 2 decades during which neurodevelopmental symptoms evolve at a rapid pace.

Identifiants

pubmed: 31494251
pii: S1053-8119(19)30746-3
doi: 10.1016/j.neuroimage.2019.116155
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116155

Investigateurs

Marie-Claude Addor (MC)
Joris Andrieux (J)
Benoît Arveiler (B)
Geneviève Baujatm (G)
Frédérique Sloan-Bénan (F)
Marco Belfiore (M)
Dominique Bonneau (D)
Sonia Bouquillon (S)
Odile Boute (O)
Alfredo Brusco (A)
Tiffany Busa (T)
Jean-Hubert Caberg (JH)
Dominique Campion (D)
Vanessa Colombert (V)
Marie-Pierre Cordier (MP)
Albert David (A)
François-Guillaume Debray (FG)
Marie-Ange Delrue (MA)
Martine Doco-Fenzy (M)
Ulrike Dunkhase-Heinl (U)
Patrick Edery (P)
Christina Fagerberg (C)
Laurence Faivre (L)
Francesca Forzano (F)
David Genevieve (D)
Marion Gérard (M)
Daniela Giachino (D)
Agnès Guichet (A)
Olivier Guillin (O)
Delphine Héron (D)
Bertrand Isidor (B)
Aurélia Jacquette (A)
Sylvie Jaillard (S)
Hubert Journel (H)
Boris Keren (B)
Didier Lacombe (D)
Sébastien Lebon (S)
Cédric Le Caignec (C)
Marie-Pierre Lemaître (MP)
James Lespinasse (J)
Michèle Mathieu-Dramart (M)
Sandra Mercier (S)
Cyril Mignot (C)
Chantal Missirian (C)
Florence Petit (F)
Kristina Pilekær Sørensen (K)
Lucile Pinson (L)
Ghislaine Plessis (G)
Fabienne Prieur (F)
Caroline Rooryck-Thambo (C)
Massimiliano Rossi (M)
Damien Sanlaville (D)
Britta Schlott Kristiansen (B)
Caroline Schluth-Bolard (C)
Marianne Till (M)
Mieke Van Haelst (M)
Lionel Van Maldergem (L)

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Alonso Cárdenas-de-la-Parra (A)

Department of Biological and Biomedical Engineering, Montreal Neurological Institute, Montreal, Quebec, Canada.

Sandra Martin-Brevet (S)

Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; LREN, Département des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

Clara Moreau (C)

CHU Sainte-Justine Research Center, Université de Montréal, Montréal, QC, Canada.

Borja Rodriguez-Herreros (B)

Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, QC, Canada.

Vladimir S Fonov (VS)

Department of Biological and Biomedical Engineering, Montreal Neurological Institute, Montreal, Quebec, Canada.

Anne M Maillard (AM)

Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Centre Cantonal Autisme, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

Nicole R Zürcher (NR)

Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Nouchine Hadjikhani (N)

Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Gillberg Neuropsychiatry Centre, Göteborg, Sweden.

Jacques S Beckmann (JS)

Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

Alexandre Reymond (A)

Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

Bogdan Draganski (B)

LREN, Département des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Sébastien Jacquemont (S)

Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, QC, Canada. Electronic address: Sebastien.jacquemont@umontreal.ca.

D Louis Collins (DL)

Department of Biological and Biomedical Engineering, Montreal Neurological Institute, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH